Raras
Buscar doenças, sintomas, genes...
Catarata total de início precoce
ORPHA:98994CID-10 · Q12.0CID-11 · LA12.1DOENÇA RARA

Síndrome de Sotos é uma alteração genética rara, no gene NSD1, descoberta nos EUA em 1964 pelo Dr. Juan Fernandez Sotos, endocrinologista pediátrico. Caracterizada principalmente pelo crescimento físico excessivo durante os primeiros anos de vida. A síndrome pode ser acompanhada de atraso neuropsicomotor e social, hipotonia, e prejuízos de fala. As crianças com síndrome de Sotos tendem a serem grandes desde o nascimento e são freqüentemente mais altas, mais pesadas, e apresentam perímetro cefálico elevado (macrocefalia) em relação a outras crianças da mesma idade, podem apresentar ainda um andar característico devido a hipotonia, o que pode ser aprimorado através da físioterapia.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Catarata total de início precoce é uma condição hereditária rara que causa opacificação completa do cristalino, levando à cegueira desde a infância. Mutações em genes como LIM2, CRYAA e HSF4 estão associadas a esta doença.

🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q12.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa10
Últimos 10 anos27publicações
Pico20216 papers
Linha do tempo
20202016Hoje · 2026📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

17 genes identificados com associação a esta condição.

Autosomal dominantAutosomal recessive
CRYBB2Beta-crystallin B2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Crystallins are the dominant structural components of the vertebrate eye lens

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Cataract 3, multiple types

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT3 includes congenital cerulean and sutural cataract with punctate and cerulean opacities, among others. Cerulean cataract is characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract. Sutural cataract with punctate and cerulean opacities is characterized by white opacification around the anterior and posterior Y sutures, and grayish and bluish, spindle shaped, oval punctate and cerulean opacities of various sizes arranged in lamellar form. The spots are more concentrated towards the peripheral layers and do not delineate the embryonal or fetal nucleus. Phenotypic variation with respect to the size and density of the sutural opacities as well as the number and position of punctate and cerulean spots is observed among affected subjects.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
3.7 TPM
Pituitária
2.0 TPM
Tireoide
1.9 TPM
Brain Nucleus accumbens basal ganglia
1.6 TPM
Hipocampo
1.3 TPM
OUTRAS DOENÇAS (8)
cataract 3 multiple typestotal early-onset cataractpulverulent cataractcerulean cataract
HGNC:2398UniProt:P43320
SIPA1L3Signal-induced proliferation-associated 1-like protein 3Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217)

LOCALIZAÇÃO

Apical cell membrane

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
24.7 TPM
Tireoide
21.2 TPM
Intestino delgado
16.6 TPM
Skin Sun Exposed Lower leg
15.8 TPM
Skin Not Sun Exposed Suprapubic
15.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
cataract 45total early-onset cataract
HGNC:23801UniProt:O60292
MIPLens fiber major intrinsic proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Aquaporins form homotetrameric transmembrane channels, with each monomer independently mediating water transport across the plasma membrane along its osmotic gradient (PubMed:11001937, PubMed:24120416). Specifically expressed in lens fiber cells, this aquaporin is crucial for maintaining lens water homeostasis and transparency. Beyond water permeability, it also acts as a cell-to-cell adhesion molecule, forming thin junctions between lens fiber cells that are essential for maintaining the ordere

LOCALIZAÇÃO

Cell membraneCell junction

VIAS BIOLÓGICAS (1)
Passive transport by Aquaporins
MECANISMO DE DOENÇA

Cataract 15, multiple types

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT15 includes polymorphic, progressive punctate lamellar, cortical, anterior and posterior polar, nonprogressive lamellar with sutural opacities, embryonic nuclear, and pulverulent cortical, among others.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.1 TPM
Fígado
0.5 TPM
Hipotálamo
0.2 TPM
Brain Spinal cord cervical c-1
0.2 TPM
Brain Frontal Cortex BA9
0.2 TPM
OUTRAS DOENÇAS (7)
cataract 15 multiple typesearly-onset lamellar cataractearly-onset nuclear cataractcerulean cataract
HGNC:7103UniProt:P30301
NHSActin remodeling regulator NHSCandidate gene tested inAltamente restrito
FUNÇÃO

May function in cell morphology by maintaining the integrity of the circumferential actin ring and controlling lamellipod formation. Involved in the regulation eye, tooth, brain and craniofacial development

LOCALIZAÇÃO

Apical cell membraneCell projection, lamellipodiumCell junction, tight junctionCell junction, focal adhesionCytoplasm

VIAS BIOLÓGICAS (3)
RAC3 GTPase cycleRAC1 GTPase cycleRAC2 GTPase cycle
MECANISMO DE DOENÇA

Nance-Horan syndrome

Rare X-linked disorder characterized by congenital cataracts, dental anomalies, dysmorphic features, and, in some cases, intellectual disability. Distinctive dental anomalies are seen in affected males, including supernumerary incisors and crown shaped permanent teeth. Characteristic facial features are anteverted pinnae, long face, and prominent nasal bridge and nose. Carrier females display milder variable symptoms of disease with lens opacities often involving the posterior Y sutures, and on occasion dental anomalies and the characteristic facial features described.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
13.7 TPM
Cervix Endocervix
13.1 TPM
Nervo tibial
12.9 TPM
Cervix Ectocervix
12.8 TPM
Artéria tibial
9.7 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
cataract 40Nance-Horan syndromeearly-onset nuclear cataracttotal early-onset cataract
HGNC:7820UniProt:Q6T4R5
AGKAcylglycerol kinase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Lipid kinase that can phosphorylate both monoacylglycerol and diacylglycerol to form lysophosphatidic acid (LPA) and phosphatidic acid (PA), respectively (PubMed:15939762). Does not phosphorylate sphingosine (PubMed:15939762). Phosphorylates ceramide (By similarity). Phosphorylates 1,2-dioleoylglycerol more rapidly than 2,3-dioleoylglycerol (By similarity). Independently of its lipid kinase activity, acts as a component of the TIM22 complex (PubMed:28712724, PubMed:28712726). The TIM22 complex m

LOCALIZAÇÃO

Mitochondrion inner membraneMitochondrion intermembrane space

VIAS BIOLÓGICAS (1)
Glycerophospholipid biosynthesis
MECANISMO DE DOENÇA

Mitochondrial DNA depletion syndrome 10

An autosomal recessive mitochondrial disorder characterized by congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, exercise intolerance, and lactic acidosis. Mental development is normal, but affected individuals may die early from cardiomyopathy.

OUTRAS DOENÇAS (3)
cataract 38Sengers syndrometotal early-onset cataract
HGNC:21869UniProt:Q53H12
LEMD2LEM domain-containing protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Nuclear lamina-associated inner nuclear membrane protein that is involved in nuclear structure organization, maintenance of nuclear envelope (NE) integrity and NE reformation after mitosis (PubMed:16339967, PubMed:17097643, PubMed:28242692, PubMed:32494070). Plays a role as transmembrane adapter for the endosomal sorting complexes required for transport (ESCRT), and is thereby involved in ESCRT-mediated NE reformation (PubMed:28242692, PubMed:32494070). Promotes ESCRT-mediated NE closure by recr

LOCALIZAÇÃO

Nucleus inner membraneNucleus envelopeCytoplasm, cytoskeleton, spindle

VIAS BIOLÓGICAS (4)
Sealing of the nuclear envelope (NE) by ESCRT-IIIInitiation of Nuclear Envelope (NE) ReformationNuclear Envelope BreakdownDepolymerization of the Nuclear Lamina
MECANISMO DE DOENÇA

Cataract 46, juvenile-onset, with or without arrhythmic cardiomyopathy

A form of cataract, an opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT46 can be associated with variable onset of a severe form of arrhythmic cardiomyopathy resulting in sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
71.2 TPM
Cérebro - Hemisfério cerebelar
70.2 TPM
Cervix Endocervix
64.7 TPM
Útero
61.0 TPM
Fallopian Tube
60.9 TPM
OUTRAS DOENÇAS (4)
Marbach-Rustad progeroid syndromecataract 46 juvenile-onsetearly-onset posterior subcapsular cataracttotal early-onset cataract
HGNC:21244UniProt:Q8NC56
DNMBPDynamin-binding proteinDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Plays a critical role as a guanine nucleotide exchange factor (GEF) for CDC42 in several intracellular processes associated with the actin and microtubule cytoskeleton. Regulates the structure of apical junctions through F-actin organization in epithelial cells (PubMed:17015620, PubMed:19767742). Participates in the normal lumenogenesis of epithelial cell cysts by regulating spindle orientation (PubMed:20479467). Plays a role in ciliogenesis (By similarity). May play a role in membrane trafficki

LOCALIZAÇÃO

CytoplasmGolgi apparatus, Golgi stackCytoplasm, cytoskeletonSynapseCell junction

VIAS BIOLÓGICAS (1)
CDC42 GTPase cycle
MECANISMO DE DOENÇA

Cataract 48

A form of cataract, an opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT48 is an autosomal recessive form characterized by infantile or early-childhood onset.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
33.6 TPM
Skin Not Sun Exposed Suprapubic
32.9 TPM
Bladder
26.3 TPM
Vagina
24.7 TPM
Cervix Ectocervix
23.4 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (2)
cataract 48total early-onset cataract
HGNC:30373UniProt:Q6XZF7
GCNT2N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells Determines the expression of the blood group I antigen in erythrocytes

LOCALIZAÇÃO

Golgi apparatus membrane

MECANISMO DE DOENÇA

Cataract 13, with adult i phenotype

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT13 is associated with the rare adult i phenotype, in which adult red blood cells are rich in i antigen and contain low levels of I antigen.

EXPRESSÃO TECIDUAL(Ubíquo)
Próstata
9.8 TPM
Estômago
7.9 TPM
Glândula salivar
6.0 TPM
Pulmão
6.0 TPM
Aorta
5.4 TPM
OUTRAS DOENÇAS (3)
obsolete blood group, 1 systemcataract 13 with adult I phenotypetotal early-onset cataract
HGNC:4204UniProt:Q8N0V5
CRYGBGamma-crystallin BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Crystallins are the dominant structural components of the vertebrate eye lens

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Cataract 39, multiple types

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT39 includes lamellar, anterior polar, and complete cataracts.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.7 TPM
Brain Spinal cord cervical c-1
0.2 TPM
Substância negra
0.1 TPM
Hipotálamo
0.0 TPM
Hipocampo
0.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (4)
cataract 39 multiple typesearly-onset lamellar cataracttotal early-onset cataractearly-onset anterior polar cataract
HGNC:2409UniProt:P07316
GJA8Gap junction alpha-8 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Structural component of eye lens gap junctions (PubMed:18006672, PubMed:19756179). Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane (By similarity). Small molecules and ions diffuse from one cell to a neighboring cell via the central pore (PubMed:18006672, PubMed:19756179)

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Cataract 1, multiple types

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT1 includes congenital, zonular pulverulent, nuclear progressive, nuclear pulverulent, nuclear total, total, and posterior subcapsular types of cataract. Zonular or lamellar cataracts are opacities, broad or narrow, usually consisting of powdery white dots affecting only certain layers or zones between the cortex and nucleus of an otherwise clear lens. The opacity may be so dense as to render the entire central region of the lens completely opaque, or so translucent that vision is hardly if at all impeded. Zonular cataracts generally do not involve the embryonic nucleus, though sometimes they involve the fetal nucleus. Usually sharply separated from a clear cortex outside them, they may have projections from their outer edges known as riders or spokes. In some cases cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
12.9 TPM
Rim - Córtex
0.0 TPM
Rim - Medula
0.0 TPM
OUTRAS DOENÇAS (7)
cataract 1 multiple typescataract - microcornea syndromepulverulent cataractsclerocornea
HGNC:4281UniProt:P48165
EPHA2Ephrin type-A receptor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation

LOCALIZAÇÃO

Cell membraneCell projection, ruffle membraneCell projection, lamellipodium membraneCell junction, focal adhesion

VIAS BIOLÓGICAS (10)
EPH-ephrin mediated repulsion of cellsEPH-Ephrin signalingRND1 GTPase cycleRHOU GTPase cycleRAC3 GTPase cycle
MECANISMO DE DOENÇA

Cataract 6, multiple types

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT6 includes posterior polar and age-related cortical cataracts, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. Age-related cortical cataract is a developmental punctate opacity restricted to the cortex. The cataract is white or cerulean, increases in number with age, but rarely affects vision.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
197.6 TPM
Vagina
101.4 TPM
Skin Not Sun Exposed Suprapubic
61.9 TPM
Skin Sun Exposed Lower leg
57.3 TPM
Nervo tibial
41.7 TPM
OUTRAS DOENÇAS (5)
cataract 6 multiple typestotal early-onset cataractearly-onset posterior polar cataractearly-onset nuclear cataract
HGNC:3386UniProt:P29317
LSSLanosterol synthaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key enzyme in the cholesterol biosynthesis pathway. Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol nucleus (PubMed:14766201, PubMed:26200341, PubMed:7639730). Through the production of lanosterol may regulate lens protein aggregation and increase transparency (PubMed:26200341)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
Lanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Cataract 44

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
93.6 TPM
Pituitária
81.3 TPM
Ovário
81.1 TPM
Cerebelo
72.7 TPM
Cervix Ectocervix
70.7 TPM
OUTRAS DOENÇAS (7)
hypotrichosis 14alopecia-intellectual disability syndrome 4cataract 44autosomal recessive palmoplantar keratoderma and congenital alopecia
HGNC:6708UniProt:P48449
FYCO1FYVE and coiled-coil domain-containing protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May mediate microtubule plus end-directed vesicle transport

LOCALIZAÇÃO

Cytoplasmic vesicle, autophagosomeEndosomeLysosome

MECANISMO DE DOENÇA

Cataract 18

An opacification of the crystalline lens of the eye becoming evident at birth or in infancy. It frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
74.0 TPM
Artéria tibial
72.6 TPM
Cólon sigmoide
54.7 TPM
Aorta
54.4 TPM
Artéria coronária
48.4 TPM
OUTRAS DOENÇAS (3)
cataract 18early-onset nuclear cataracttotal early-onset cataract
HGNC:14673UniProt:Q9BQS8
PGRMC1Membrane-associated progesterone receptor component 1Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of a progesterone-binding protein complex (PubMed:28396637). Binds progesterone (PubMed:25675345). Has many reported cellular functions (heme homeostasis, interaction with CYPs). Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). Intracellular heme chaperone. Regulates heme synthesis via interactions with FECH and acts as a heme donor for at least some hemoproteins (PubMed:27599036). Forms a ternary complex with TMEM97 rec

LOCALIZAÇÃO

Microsome membraneSmooth endoplasmic reticulum membraneMitochondrion outer membraneSecreted

VIAS BIOLÓGICAS (1)
Neutrophil degranulation
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
240.5 TPM
Glândula adrenal
235.2 TPM
Aorta
234.9 TPM
Brain Spinal cord cervical c-1
228.8 TPM
Fibroblastos
220.7 TPM
OUTRAS DOENÇAS (1)
total early-onset cataract
HGNC:16090UniProt:O00264
HSF4Heat shock factor protein 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Heat-shock transcription factor that specifically binds heat shock promoter elements (HSE) (PubMed:22587838, PubMed:23507146). Required for denucleation and organelle rupture and degradation that occur during eye lens terminal differentiation, when fiber cells that compose the lens degrade all membrane-bound organelles in order to provide lens with transparency to allow the passage of light (By similarity). In this process, may regulate denucleation of lens fiber cells in part by activating DNAS

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Cataract 5, multiple types

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT5 includes infantile, lamellar, zonular, nuclear, anterior polar, stellate, and Marner-type cataracts, among others. Finger malformation is observed in some kindreds.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
150.5 TPM
Cérebro - Hemisfério cerebelar
137.8 TPM
Pituitária
136.0 TPM
Próstata
108.1 TPM
Fallopian Tube
103.8 TPM
OUTRAS DOENÇAS (3)
cataract 5 multiple typesearly-onset lamellar cataracttotal early-onset cataract
HGNC:5227UniProt:Q9ULV5
CRYAAAlpha-crystallin A chainDisease-causing germline mutation(s) inModerado
FUNÇÃO

Contributes to the transparency and refractive index of the lens (PubMed:18302245). In its oxidized form (absence of intramolecular disulfide bond), acts as a chaperone, preventing aggregation of various proteins under a wide range of stress conditions (PubMed:18199971, PubMed:19595763, PubMed:22120592, PubMed:31792453). Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA (PubMed:28935373)

LOCALIZAÇÃO

CytoplasmNucleus

EXPRESSÃO TECIDUAL(Baixa expressão)
Rim - Medula
3.3 TPM
Rim - Córtex
0.2 TPM
Fígado
0.0 TPM
OUTRAS DOENÇAS (6)
cataract 9 multiple typesearly-onset nuclear cataractearly-onset lamellar cataracttotal early-onset cataract
HGNC:2388UniProt:P02489
LIM2Lens fiber membrane intrinsic proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Present in the thicker 16-17 nm junctions of mammalian lens fiber cells, where it may contribute to cell junctional organization. Acts as a receptor for calmodulin. May play an important role in both lens development and cataractogenesis

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Cataract, multiple types 19

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function.

EXPRESSÃO TECIDUAL(Não detectado)
Sangue
0.5 TPM
Testículo
0.3 TPM
Baço
0.2 TPM
Pulmão
0.1 TPM
Rim - Medula
0.0 TPM
OUTRAS DOENÇAS (2)
cataract 19 multiple typestotal early-onset cataract
HGNC:6610UniProt:P55344

Variantes genéticas (ClinVar)

187 variantes patogênicas registradas no ClinVar.

🧬 LIM2: NM_001161748.2(LIM2):c.128G>A (p.Trp43Ter) ()
🧬 LIM2: GRCh37/hg19 19q13.33-13.43(chr19:49625130-57647352)x3 ()
🧬 LIM2: NC_000019.9:g.(?_51727962)_(51890697_?)del ()
🧬 LIM2: GRCh37/hg19 19q13.33-13.41(chr19:49911081-53127438) ()
🧬 LIM2: NM_001161748.2(LIM2):c.281G>A (p.Arg94His) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Catarata total de início precoce

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry.

Ophthalmology and therapy2025 Nov

This study aims to describe complications of pediatric-onset uveitis and their predictors among baseline and treatment-related factors. This registry-based observational study included patients with noninfectious uveitis with disease onset < 18 years. A total of 309 patients were enrolled (535 eyes). Uveitis was anterior in 290 eyes (54.2%), panuveitis in 121 (22.6%), intermediate in 88 (16.4%), and posterior in 24 (4.5%). Over a median follow-up of 49.0 months (interquartile range [IQR] 101.0), 137 children (44.3%) developed ≥ 1 complication (14.4 per 100 patient-years). Idiopathic uveitis (p < 0.001), longer topical glucocorticoid (GC) monotherapy (p < 0.001) and longer delay of immunosuppressive therapy (IST) (p = 0.03) were associated with a higher frequency of complications. In multivariate analysis, anterior uveitis was protective against complications (odds ratio [OR] 0.10, 95% confidence interval [CI] - 4.1 to - 1.6, p < 0.001), whereas a chronic course of uveitis significantly increased the risk (OR 6.13, 95% CI 1.0-2.6, p < 0.001). Older age at onset was protective against cataract (OR 0.91, 95% CI - 0.2 to - 0.02, p = 0.020) and band keratopathy (OR 0.8, 95% CI - 0.4 to - 0.1, p = 0.003). Final best-corrected visual acuity (BCVA) (Snellen decimals) was inversely correlated with the duration of topical GC monotherapy (ρ = - 0.23; p = 0.001). In multivariate analysis, panuveitis was linked to a 0.142 decimal reduction (95% CI - 0.219 to - 0.066, p < 0.001), and cataract to a 0.295 reduction (95% CI - 0.372 to - 0.217, p < 0.001) in the final BCVA. Children with chronic, idiopathic, early-onset, and non-anterior uveitis are at greatest risk for complications. Structured screening for these children, along with early initiation of systemic IST, is essential to prevent visual impairment.

#2

Severe clinical manifestation of mitochondrial disease due to the m.3243A>T variant: a case report of early-onset, multi-organ involvement and premature death.

Journal of rare diseases (Berlin, Germany)2025

The spectrum of disease associated with pathogenic mitochondrial DNA (mtDNA) variants is wide. Most often, heteroplasmic mitochondrial DNA disease is the result of an adenine to guanine transition at position 3243 of mtDNA (m.3243A > G) in the MT-TL1 gene encoding tRNALeu(UUR). Here, we present a case of a patient with a rarer m.3243A > T variant whose phenotype was severe and included delayed growth, developmental delay, myoclonic jerks and tonic-clonic seizures, progressive myopathy, cerebellar ataxia, severe malnutrition due to intestinal dysmotility despite naso-jejunal feeding requiring total parenteral nutrition, bilateral sensorineural hearing loss, and visual impairment, including bilateral cataracts requiring treatment and pigmentary retinopathy. At age 18 years, he developed severe nephrotic syndrome secondary to a membranoproliferative pattern of glomerular injury, which was resistant to treatment and led to premature death.

#3

The efficacy of non-depolarizing muscle relaxant as adjuvants to local anesthesia in peribulbar block during cataract surgery.

Scientific reports2025 Jan 29

Peribulbar anesthesia is mainly used for cataract surgery. Many studies had used atracurium and rocuronium as an additive to the local anesthetic (LA) drugs in eye surgery. The aim of this study is to evaluate the efficacy of adding atracurium versus rocuronium to a local anesthetic mixture, in providing an early onset of orbital akinesia and corneal anesthesia during cataract surgery. Ninety-three patients met the inclusion criteria and gave a written informed consent to participate. Patients were randomly allocated in three study groups (31 patients in each group). Group I received either 3 mL of a lidocaine2%(mixed by hyaluronidase 50 IU/ml) and 3 ml bupivacaine mixture, plus 0.5 mL rocuronium (5 mg) total volume 6.5 ml. Group II 3 mL of a lidocaine2%(mixed by hyaluronidase 50 IU/ml) and 3 ml bupivacaine mixture plus 0.5 mL (5 mg) atracurium total volume 6.5 ml. Group III or3 mL of a lidocaine2%(mixed by hyaluronidase 50 IU/ml) and - 3 ml bupivacaine mixture, plus 0.5 mL saline total volume 6.5 ml. The onset time of orbital akinesia was significantly lower in the rocuronium group and the atracurium group compared to the control group. Akinesia score was (0.90 ± 0.30) and (0.19 ± 0.40) in rocuronium group at 4 min and 6 min respectively which result in highly significant difference than atracurium and control groups. The use of rocuronium and atracurium will result in rapid orbital akinesia and rapid orbicularis muscle akinesia.

#4

Autosomal Dominant Retinitis Pigmentosa Secondary to TOPORS Mutations: A Report of a Novel Mutation and Clinical Findings.

Journal of clinical medicine2024 Mar 05

Purpose: Mutations in Topoisomerase I-binding RS protein (TOPORS) have been previously documented and have been described to result in pathological autosomal dominant retinitis pigmentosa (adRP). In our study, we describe the various genotypes and clinical/phenotypic manifestations of TOPORS-related mutations of our unique patient population in Rural Appalachia. Methods: The medical records of 416 patients with inherited retinal disease at the West Virginia University Eye Institute who had undergone genetic testing between the years of 2015-2022 were reviewed. Patients found to have pathologic RP and mutations related to TOPORS were then analyzed. Results: In total, 7 patients (ages 12-70) were identified amongst three unique families. All patients were female in our study. The average follow-up period was 7.7 years. A mother (70 yr) and daughter (51 yr) had a novel heterozygous nonsense point mutation in TOPORS c.2431C > T, p.Gln811X (Exon 3) that led to premature termination of the desired protein resulting in early onset vision loss, cataract formation, and visual field restriction. The mother developed a full-thickness macular hole which was successfully repaired. Five other patients were found to have previously described TOPORS mutations. Visual field loss was progressive with age in both cohorts. Conclusions: Seven patients at our institution were identified to have mutations in TOPORS resulting in autosomal dominant retinitis pigmentosa. Two patients were found to have novel truncating mutations in the TOPORS gene resulting in profound night blindness and visual field loss, recurrent macular edema, and in one individual, epiretinal membrane formation leading to a macular hole which was able to be successfully repaired.

#5

Demographic profile and clinical characteristics of Fuchs' endothelial corneal dystrophy in a tertiary eye care center.

Indian journal of ophthalmology2023 Feb

This study was performed to determine the demographic profile and clinical characteristics in patients with Fuchs' endothelial corneal dystrophy (FECD) reporting to a tertiary eye care center in India. It is a retrospective, single-center, observational study. The study included 280 patients (559 eyes) diagnosed with FECD presenting between January 2013 and December 2020. The data was collected from the electronic medical record system of the institute. Patient data included demographic features, clinical characteristics, investigations, and surgical interventions. The mean age of the patients was 62 years. Late-onset FECD (95.7%) was more common than early-onset FECD (4.3%). Male: female ratio for late-onset FECD and early-onset FECD was 1:1.65 and 3:1, respectively. More than one-third of the patients had associated systemic history. Preexisting ocular diseases were seen in 5.9% of eyes. Blurring of vision was seen in 383 eyes (68.5%), 13 eyes (2.1%) had glare, and 163 eyes (29.2%) were asymptomatic. A total of 113 surgical interventions were done in 108 eyes (including repeat transplants). Only cataract surgery was done in 40 (7.2%) eyes, whereas penetrating keratoplasty, Descemet stripping endothelial keratoplasty, and Descemet membrane endothelial keratoplasty without or with cataract surgery (sequential or triple procedure) were done in 12 (2.1%), 47 (8.4%), and 14 (2.5%) eyes, respectively. Patients with FECD present mostly during the sixth decade. Posterior lamellar keratoplasty is the most common transplant procedure being performed on FECD patients.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 27

2025

Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry.

Ophthalmology and therapy
2025

Severe clinical manifestation of mitochondrial disease due to the m.3243A>T variant: a case report of early-onset, multi-organ involvement and premature death.

Journal of rare diseases (Berlin, Germany)
2025

The efficacy of non-depolarizing muscle relaxant as adjuvants to local anesthesia in peribulbar block during cataract surgery.

Scientific reports
2024

Autosomal Dominant Retinitis Pigmentosa Secondary to TOPORS Mutations: A Report of a Novel Mutation and Clinical Findings.

Journal of clinical medicine
2023

Demographic profile and clinical characteristics of Fuchs' endothelial corneal dystrophy in a tertiary eye care center.

Indian journal of ophthalmology
2023

Late-onset glaucoma following congenital cataract surgery: Occurrence, visual acuity and risk factors: A 37-year longitudinal follow-up.

Acta ophthalmologica
2022

Risk Factor Analysis of Early-Onset Cataracts in Taiwan.

Journal of clinical medicine
2022

Uveitis, glaucoma, and cataract with mevalonate kinase deficiency.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2022

Retrospective Analysis of Cataract Formation and Nutritional Etiology in a Managed Collection of Parakeet Auklets (Aethia psittacula).

Journal of avian medicine and surgery
2021

Manifestation of Panuveitis after Intraocular Surgery in a Child with Blau Syndrome.

Middle East African journal of ophthalmology
2022

Association of neovascular age-related macular degeneration with migraine.

Scientific reports
2021

Body mass index is not associated with early onset cataract in the 45 and Up cohort study.

Annals of translational medicine
2022

Early-Onset Posterior Capsule Opacification: Incidence, Severity, and Risk Factors.

Ophthalmology and therapy
2021

The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective.

Genes
2021

Findings from the 45 and Up Study: smoking is not associated with the risk of early-onset cataract.

Annals of translational medicine
2021

Effect of hydrophilic and lipophilic statins on early onset cataract: A nationwide case-control study.

Regulatory toxicology and pharmacology : RTP
2021

Outcomes of Primary Combined Trabeculotomy and Trabeculectomy in Early-Onset Glaucoma in Children with Congenital Aniridia.

Ophthalmology. Glaucoma
2020

Alpha-crystallin mutations alter lens metabolites in mouse models of human cataracts.

PloS one
2020

Hereditary cataract in the Bengal cat in Poland.

BMC veterinary research
2019

Prevalence of Cerebrotendinous Xanthomatosis Among Patients Diagnosed With Acquired Juvenile-Onset Idiopathic Bilateral Cataracts.

JAMA ophthalmology
2019

Presenile cataract and its risk factors: A case control study.

Journal of family medicine and primary care
2019

Movement disorders in cerebrotendinous xanthomatosis.

Parkinsonism &amp; related disorders
2018

Hereditary cataracts in Russian Blue cats.

Journal of feline medicine and surgery
2017

Preeclampsia and the risk of cataract extraction in life.

American journal of obstetrics and gynecology
2016

[Clinical analysis of aphakic glaucoma following infantile congenital cataract surgery].

Zhonghua yi xue za zhi
2016

Ocular findings in patients with alopecia areata.

International journal of dermatology
2016

Prognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS).

Journal of the American Academy of Dermatology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Catarata total de início precoce.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Catarata total de início precoce

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry.
    Ophthalmology and therapy· 2025· PMID 40983853mais citado
  2. Severe clinical manifestation of mitochondrial disease due to the m.3243A&gt;T variant: a case report of early-onset, multi-organ involvement and premature death.
    Journal of rare diseases (Berlin, Germany)· 2025· PMID 40787093mais citado
  3. The efficacy of non-depolarizing muscle relaxant as adjuvants to local anesthesia in peribulbar block during cataract surgery.
    Scientific reports· 2025· PMID 39880846mais citado
  4. Autosomal Dominant Retinitis Pigmentosa Secondary to TOPORS Mutations: A Report of a Novel Mutation and Clinical Findings.
    Journal of clinical medicine· 2024· PMID 38592336mais citado
  5. Demographic profile and clinical characteristics of Fuchs' endothelial corneal dystrophy in a tertiary eye care center.
    Indian journal of ophthalmology· 2023· PMID 36727349mais citado
  6. Late-onset glaucoma following congenital cataract surgery: Occurrence, visual acuity and risk factors: A 37-year longitudinal follow-up.
    Acta Ophthalmol· 2023· PMID 36036699recente
  7. Uveitis, glaucoma, and cataract with mevalonate kinase deficiency.
    J AAPOS· 2022· PMID 35158047recente
  8. Retrospective Analysis of Cataract Formation and Nutritional Etiology in a Managed Collection of Parakeet Auklets (Aethia psittacula).
    J Avian Med Surg· 2022· PMID 35142164recente
  9. The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective.
    Genes (Basel)· 2021· PMID 34573385recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98994(Orphanet)
  2. MONDO:0021548(MONDO)
  3. GARD:1159(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q27674906(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Catarata total de início precoce
Compêndio · Raras BR

Catarata total de início precoce

ORPHA:98994 · MONDO:0021548
CID-10
Q12.0 · Catarata congênita
CID-11
Início
Infancy, Neonatal
MedGen
UMLS
C0266539
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades